Trial: 202205085

A Phase 1a/1b, Open-Label, Multicenter Study Evaluating the Safety and Feasibility of ITIL-306 in Subjects with Advanced Solid Tumors

Phase

I

Principal Investigator

Ward, Jeffrey

Disease Site

Kidney; Lung; Ovary

Learn more about this study at: clinicaltrials.gov